Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
LakeShore Biopharma Reports Unaudited Financial Results for the First Half of Fiscal Year 2025 and Updates Full-Year Guidance 2024-12-19 22:05
MGI Tech Closes Agreement with Sabin Group to Boost Personalized Medicine in Brazil through Oncological and Germiline Genomics 2024-12-19 17:42
LG Corp. Chairman and CEO Kwang Mo Koo sends 2025 New Year Address to 270,000 global employees on December 19 2024-12-19 13:00
Fangzhou Inc. and Bristol Myers Squibb China Join Forces on a Strategic Alliance to Advance Internet Healthcare 2024-12-19 12:40
Clarity expands its pipeline with a novel optimised FAP-targeted radiopharmaceutical 2024-12-18 22:03
Juncell Therapeutics Opens State-of-the-Art Facility for TIL Production 2024-12-18 21:08
Samsung invests in Generate: Biomedicines to advance AI-driven protein therapeutics discovery 2024-12-18 13:09
U.S. FDA approves Celltrion's STEQEYMA® (ustekinumab-stba), a biosimilar to STELARA® (ustekinumab) 2024-12-18 11:50
Origin Agritech Holds Successful 2025 R&D and Business Management Conference 2024-12-17 21:00
Great Bay Bio Completes First Close of Series B Financing 2024-12-17 16:42
SK Biopharmaceuticals Inks Research Collaboration Agreement with ProEn Therapeutics Further Accelerating Expansion of Oncology Research and Pipeline for Global Competitiveness in Radiopharmaceuticals 2024-12-17 08:20
Samsung Biologics listed among top most sustainable companies in Dow Jones Sustainability World Index 2024-12-17 07:51
Microbio Co., Ltd. (4128) Announces Promising Results of "MS-20" in Combination with Keytruda for Stage IIIb/IV Non-Small Cell Lung Cancer 2024-12-17 02:05
Nona Biosciences Announces Discovery Collaboration with Candid Therapeutics for Next-Generation T-Cell Engagers 2024-12-16 20:03
Young International Scientists Say: China-Myanmar Partnership Advances Agricultural Innovation 2024-12-13 18:21
Accropeutics Inc. Announces U.S. FDA Clearance of IND Application for RIPK2 Inhibitor AC-101 2024-12-13 12:57
Transcenta Debuts Promising Anti-Tumor Activity of Novel LIV-1 Targeting ADCs with Site-Specific Conjugated Topo I Inhibitor Payload in TNBC Tumor Models at 2024 SABCS 2024-12-13 08:00
Bota Bio debuted the 2024 FiE and launched its subsidiary HeliaGenesis, focusing on food and nutrition industries 2024-12-12 22:00
CureGene Received Clinical Trial Approval in China for CG-0255 for Injection - A Novel Antiplatelet Therapy 2024-12-12 21:00
Porton Pharma Solutions and Aojin Life Sciences Announce Strategic Collaboration to Advance XDC Conjugate Drugs for Dual IND Filings in China and the U.S. 2024-12-12 21:00
1 2 3 4 5 226